CD38-RyR2 axis-mediated signaling impedes CD8+ T cell response to anti-PD1 therapy in cancer.
Kar A, Ghosh P, Gautam A, Chowdhury S, Basak D, Sarkar I, Bhoumik A, Barman S, Chakraborty P, Mukhopadhyay A, Mehrotra S, Ganesan SK, Paul S, Chatterjee S.
Kar A, et al. Among authors: sarkar i.
Proc Natl Acad Sci U S A. 2024 Mar 12;121(11):e2315989121. doi: 10.1073/pnas.2315989121. Epub 2024 Mar 7.
Proc Natl Acad Sci U S A. 2024.
PMID: 38451948
Free PMC article.